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This study was directed to obtain a carbamazepine nanoemulsion for intravenous administration 
which consists of medium-chain trigycerides (Myritol) used as oil phase and Tween 80 as emulsifier. The 
spontaneous emulsification method with additional sonication was used to prepare different formulation 
containing 0.5 mg/ml carbamazepine. The nanoemulsions were evaluated concerning droplet size, zeta po-
tential and drug content. Preliminary studies of anticonvulsant activity for resulting formulation were car-
ried out.  
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1. INTRODUCTION 
 
Carbamazepine (CBZ), 5H-dibenz(b,f)asepine-5-
carboxamide is one of the widely used drugs in medical 
practice for the treatment of patients with epilepsy. 
However, very poor water solubility of drug 
(0.061 mg/ml) leads to its slow absorption from the gas-
trointestinal tract [1], which significantly reduces bioa-
vailability and the overall effectiveness of therapy. Also 
still there is no dosage form of CBZ for parenteral ad-
ministration, which is extremely important in emer-
gency assistance in case such as coma, swallowing 
problems and others. In this regard there is a very ac-
tual problem to producing a water-soluble CBZ formu-
lation. One of the most suitable solutions to solve this 
problem is to create a different kind of emulsions. 
Emulsion formulations offer an appealing alternative 
for the administration of poorly water soluble drugs 
due to their effectiveness for drug solubilization, poten-
tial for improved efficacy and anticipated patient ac-
ceptance and compliance due to the reduced side effects 
[2]. At present time there is an urgent problem in 
choosing the conditions for the simultaneous achieve-
ment of stability and inclusion of high percentage of 
drug in the emulsion. 
 
2. MATERIALS AND METHODS 
 
We used the following devices: ultrasonic bath (Son-
orex TK-52, Germany), magnetic stirrer Ika RH basic 
(Ika Labortechnik, Germany), pH meter (Mettler Tole-
do, Germany), spectrophotometer (Shimadzu UV-1700, 
Japan), the chromatographic separation system of the 
high pressure (Beckman-Coulter, USA), a rotary evapo-
rator (Heidolph, Germany). 
The particle size distribution was determined by the 
autocorrelation spectrometer «DelsaNano» (Beckman-
Coulter, USA). 
The convulsions test induced by maximal electro-
shock, was carried out on the unit Rodent Shocker RS 
type 221 (Harvard Apparatus, GmbH) by the applica-
tion of electrical stimulation (0.3 ms, 24-25 mA, voltage 
700 V - for mice C57Bl/6 and weighing 20-22 g) through 
cranial electrodes. 
For preparing emulsions we used the following rea-
gents: carbamazepine (Sigma-Aldrich, Germany), Myri-
tol 312 (Fluka, Switzerland), Tween 80 (Sigma-Aldrich, 
Germany), sodium deoxycholate (Sigma-Aldrich Ger-
many), pharmacology grade DMSO (Fluka, Switzer-
land). HPLC grade tetrahydrofuran and ethanol were 
purchased from Sigma-Aldrich Germany 
 
3. RESULTS AND DISCUSSION 
 
To achieve the above goal, the investigation was 
carried out in several stages: optimization of qualita-
tive and quantitative composition of CBZ emulsion, 
study of physicochemical parameters resulting disper-
sions (particle size, zeta potential, morphology, aggre-
gation stability) and research of anticonvulsant activity 
for obtained CBZ formulations. 
The method of spontaneous emulsification previous-
ly described by Kelman et al. [3] with additional soni-
cation step was used to prepare different formulation 
containing 0.5 mg/ml CBZ. It has been proposed to add 
the sodium deoxycholate to the emulsion because of its 
good structure-forming properties and charge genera-
tion on interfacial surface of dispersions. 
CBZ concentration in emulsions was measured by 
two different methods: spectrophotometric method and 
high performance liquid chromatography (HPLC), and 
the values obtained by both methods were identical. 
No precipitation was observed in the prepared sam-
ples, which can be explained by the fact that CBZ is 
well included in the dispersed phase. The sample 
showed good stability for one month at a temperature 
of 4 ºC; however, the value of the zeta potential was not 
high enough and was – 23 mV. The particle size and its 
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distribution were obtained using size analyzer and rep-
resented in Figure 1. In order to get rid of substances 
unincorporated into droplets, the sample obtained us-
ing centrifugation at 10,000 rpm for 15 minutes at 
25 ºC.  
Figure 1 shows that the sample is present in a frac-
tion of particles with an average diameter of 96 nm. 
 
 
 
Fig. 1 – The particle size distribution for CBZ emulsion 
 
In maximum electroshock test we used following 
scoring system, where "0 points" correspond to the ab-
sence of seizures, "1 point" – clonic convulsions, "2 
points" – the tone of the upper limbs and clonic spasms 
of the hind limbs, "3 points" – tonic extension of hind 
limbs and "four points" – the death of animals. The 
results of the study are shown in Table 1. 
Table 1 – Anticonvulsant activity for CBZ emulsion form 
comparison with carbamazepine in the substance model 
convulsions induced by maximal electroshock in mice of the 
C57Bl/6 
 
Group/dose Convulsions, 
points 
The number 
of surviving 
animals, % 
The control 
group 
3.72 ± 0.19 28.6 
Carbamazepine 
substance 
20 mg/kg 
1.75 ± 0.48 100 
Emulsion of 
carbamazepine, 
10 mg/kg 
3.00 ± 0.0 100 
 
4. CONCLUSION 
 
These studies revealed anticonvulsant carbamaze-
pine emulsion forms in a dose of 10 mg/kg, but at the 
same time there were some side effects, suggesting the 
need for additional experiments to determine the caus-
es of the latter.  
Thus, in this paper we propose a technique to obtain 
stable emulsions CBZ and revealed their anticonvul-
sant activity. 
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